| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | | 6 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUPPOSITORY / RECTAL | 14 mg | | Exact identifier — unii candidate 49 equally ranked IID candidates |
| Aspartame | ASPARTAME | Z0H242BBR1 | TABLET, CHEWABLE / ORAL | | 195 mg | Exact identifier — unii candidate 19 equally ranked IID candidates |
| Maltodextrin | MALTODEXTRIN | 7CVR7L4A2D | CAPSULE / ORAL | | 200 mg | Exact identifier — unii candidate 15 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / ORAL | | 400 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | OIL / TOPICAL | | 2 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FOR SUSPENSION / ORAL | | 220 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / RESPIRATORY (INHALATION) | | 1 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | PASTE / ORAL | | 26 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | | 168 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE / ORAL | | 131 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | | 619 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY / TOPICAL | 0.01 %w/w | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | TROCHE / ORAL | | 26 mg | Exact identifier — unii candidate 17 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / SUBLINGUAL | ADJ PH | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY, METERED / NASAL | 1.2 mg/1ml | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | | Exact identifier — unii candidate 49 equally ranked IID candidates |
| Aspartame | ASPARTAME | Z0H242BBR1 | TABLET, FOR SUSPENSION / ORAL | | 15 mg | Exact identifier — unii candidate 19 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE / ORAL | 5000 mg | | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| Aspartame | ASPARTAME | Z0H242BBR1 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | | 18 mg | Exact identifier — unii candidate 19 equally ranked IID candidates |
| Aspartame | ASPARTAME | Z0H242BBR1 | FILM, EXTENDED RELEASE / BUCCAL | | 1 mg | Exact identifier — unii candidate 19 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | | 81 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAVENOUS | | 1152 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | | 7258 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE PARTICLES / ORAL | | 170 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / SUBCUTANEOUS | | 25 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| Aspartame | ASPARTAME | Z0H242BBR1 | CAPSULE, EXTENDED RELEASE / ORAL | | 3 mg | Exact identifier — unii candidate 19 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | LOZENGE / TRANSMUCOSAL | | 1255 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET / ORAL | | 197 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | ELIXIR / ORAL | | 90 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION / ORAL | | 400 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | | 750 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / RECTAL | | 904 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INFILTRATION | 0.02 %w/v | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE / ORAL | | 3568 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | | 48209 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| Aspartame | ASPARTAME | Z0H242BBR1 | POWDER, FOR SOLUTION / ORAL | 233 mg | | Exact identifier — unii candidate 19 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SOLUTION / ORAL | 1.8 mg/120ml | | Exact identifier — unii candidate 49 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | | 35 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / ORAL | | 46 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | | 602 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | POWDER, FOR SUSPENSION / ORAL | | 570 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / ORAL | | 3900 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | | Exact identifier — unii candidate 48 equally ranked IID candidates |
| Maltodextrin | MALTODEXTRIN | 7CVR7L4A2D | TABLET, CHEWABLE / ORAL | 292 mg | | Exact identifier — unii candidate 15 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION/ DROPS / ORAL | | 15 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | GEL / TOPICAL | | 3 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / DENTAL | 19 %w/w | | Exact identifier — unii candidate 49 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / OPHTHALMIC | 0.09 %w/v | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | TABLET, FILM COATED / ORAL | 1.75 mg | | Exact identifier — unii candidate 17 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | | 18790 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | | 86 mg | Exact identifier — unii candidate 48 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM, SOLUBLE / ORAL | | 7 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | GRANULE, FOR SUSPENSION / ORAL | | 30 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| Aspartame | ASPARTAME | Z0H242BBR1 | TABLET / SUBLINGUAL | | 8 mg | Exact identifier — unii candidate 19 equally ranked IID candidates |
| Maltodextrin | MALTODEXTRIN | 7CVR7L4A2D | TABLET, EFFERVESCENT / ORAL | | 14404 mg | Exact identifier — unii candidate 15 equally ranked IID candidates |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | | 3 mg | Exact identifier — unii candidate 49 equally ranked IID candidates |